Literature DB >> 2713507

The mechanism of plasminogen activation and fibrin dissolution by single chain urokinase-type plasminogen activator in a plasma milieu in vitro.

H R Lijnen1, B Van Hoef, F De Cock, D Collen.   

Abstract

The relative contribution of several mechanisms to plasminogen activation and fibrin dissolution by urokinase-type plasminogen activator (u-PA) in vitro was quantitated. The activation of plasminogen by recombinant single chain u-PA (rscu-PA), by its two chain derivative (rtcu-PA) and by a plasmin-resistant mutant, rscu-PA-Glu158, obeys Michaelis-Menten kinetics with catalytic efficiencies of 0.00064, 0.046, and 0.00005 L/mumol.s for native plasminogen (Glu-plasminogen) and of 0.0061, 1.21, and 0.0004 L/mumol.s for partially degraded plasminogen (Lys-plasminogen). In a purified system consisting of a fibrin clot submerged in a plasminogen solution, the equi-effective doses (50% lysis in one hour) for rscu-PA, rtcu-PA, and rscu-PA-Glu158 were 16, 6.5, and 32,000 ng/mL for Glu-plasminogen and two- to fourfold lower for Lys-plasminogen. In a plasma milieu, 50% lysis in two hours was obtained for a plasma clot with 2.1 micrograms/mL rscu-PA, 0.5 micrograms/mL rtcu-PA, and greater than 200 micrograms/mL rscu-PA-Glu158 and for a purified fibrin clot with 1.3 micrograms/mL rscu-PA and 0.27 microgram/mL rtcu-PA. After predigestion of a purified fibrin clot with plasmin, the apparent potency of rscu-PA and rtcu-PA increased by 40% and 20%, respectively. In conclusion, rscu-PA has an intrinsic plasminogen activating potential that is only about 1% of that of rtcu-PA and that is 13 times higher than that of rscu-PA-Glu158. Conformational transition of Glu-plasminogen to Lys-plasminogen enhances its sensitivity to activation by all u-PA moieties ten- to 20-fold. Predigestion of fibrin clots with associated increased binding of plasminogen results in a minor apparent increase of the fibrinolytic potency of rscu-PA and rtcu-PA. The relative fibrinolytic potency of rtcu-PA is two to three orders of magnitude higher than that of rscu-PA-Glu158 but only two- to five-fold higher than that of rscu-PA, both in purified systems and in a plasma milieu. These results indicate that conversion of rscu-PA to rtcu-PA constitutes the primary mechanism of fibrin dissolution.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2713507

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  9 in total

1.  Steady states and dynamics of urokinase-mediated plasmin activation in silico and in vitro.

Authors:  Lakshmi Venkatraman; Huipeng Li; C Forbes Dewey; Jacob K White; Sourav S Bhowmick; Hanry Yu; Lisa Tucker-Kellogg
Journal:  Biophys J       Date:  2011-10-19       Impact factor: 4.033

2.  Inner clot diffusion and permeation during fibrinolysis.

Authors:  S L Diamond; S Anand
Journal:  Biophys J       Date:  1993-12       Impact factor: 4.033

3.  Differentiating pharmacologic agents used in catheter-directed thrombolysis.

Authors:  James L Swischuk; H Bob Smouse
Journal:  Semin Intervent Radiol       Date:  2005-06       Impact factor: 1.513

Review 4.  Plasminogen activator receptor assemblies in cell signaling, innate immunity, and inflammation.

Authors:  Steven L Gonias
Journal:  Am J Physiol Cell Physiol       Date:  2021-08-18       Impact factor: 5.282

Review 5.  Evaluation of thrombolytic agents.

Authors:  W R Bell
Journal:  Drugs       Date:  1997       Impact factor: 9.546

6.  Plasmin triggers a switch-like decrease in thrombospondin-dependent activation of TGF-β1.

Authors:  Lakshmi Venkatraman; Ser-Mien Chia; Balakrishnan Chakrapani Narmada; Jacob K White; Sourav S Bhowmick; C Forbes Dewey; Peter T So; Lisa Tucker-Kellogg; Hanry Yu
Journal:  Biophys J       Date:  2012-09-05       Impact factor: 4.033

7.  A novel ultrasound-based method to evaluate hemostatic function of whole blood.

Authors:  Francesco Viola; F William Mauldin; Xiefan Lin-Schmidt; Doris M Haverstick; Michael B Lawrence; William F Walker
Journal:  Clin Chim Acta       Date:  2009-10-25       Impact factor: 3.786

8.  Thrombin generates monocyte chemotactic activity from complement factor H.

Authors:  H Ohtsuka; T Imamura; M Matsushita; S Tanase; H Okada; M Ogawa; T Kambara
Journal:  Immunology       Date:  1993-09       Impact factor: 7.397

Review 9.  Novel thrombolytic agents.

Authors:  M Verstraete; H R Lijnen
Journal:  Cardiovasc Drugs Ther       Date:  1994-12       Impact factor: 3.727

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.